To treat or not to treat, that is the NLPHL question
- PMID: 31097532
- DOI: 10.1182/blood-2019-02-900811
To treat or not to treat, that is the NLPHL question
Conflict of interest statement
Conflict-of-interest disclosure: J.M.C. has received honoraria from Seattle Genetics and Takeda Pharmaceuticals.
Comment on
-
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma.Blood. 2019 May 16;133(20):2121-2129. doi: 10.1182/blood-2018-10-877761. Epub 2019 Feb 15. Blood. 2019. PMID: 30770396 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical

